Works by Zernhelt, Adriane M.

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.

Published in:

Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1

By:

• Rhoda Molife, L.;
• Li Yan;
• Vitfell-Rasmussen, Joanna;
• Zernhelt, Adriane M.;
• Sullivan, Daniel M.;
• Cassier, Philippe A.;
• Eric Chen;
• Biondo, Andrea;
• Tetteh, Ernestina;
• Siu, Lillian L.;
• Patnaik, Amita;
• Papadopoulos, Kyriakos P.;
• De Bono, Johann S.;
• Tolcher, Anthony W.;
• Minton, Susan

Publication type:

Article